Utility Menu

National Association of Pharmacy Regulatory Authorities


Main navigation

Ephedrine and its salts in combination products

in preparations containing no more than 8 mg per unit dose, with a label recommending no more than 8 mg/dose or 32 mg/day and for use not more than 7 days, and indicated for nasal congestion.

Approval Date:

Schedule: III